Project Start
1999-04-12
Project End
2006-04-11
Budget Start
2000-08-30
Budget End
2002-04-11
Support Year
Fiscal Year
2000
Total Cost
$495,467
Indirect Cost
Name
Focus/Mrl, Inc.-Mrl Pharmaceutical Services
Department
Type
DUNS #
City
Herndon
State
VA
Country
United States
Zip Code
20171
Yang, Junshu; Ji, Yinduo (2014) Investigation of Staphylococcus aureus adhesion and invasion of host cells. Methods Mol Biol 1085:187-94
Prabhakara, Ranjani; Foreman, Oded; De Pascalis, Roberto et al. (2013) Epicutaneous model of community-acquired Staphylococcus aureus skin infections. Infect Immun 81:1306-15
Brady, Rebecca A; Mocca, Christopher P; Prabhakara, Ranjani et al. (2013) Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection. PLoS One 8:e63040
Kim, Eu Suk; Lee, Hye Jin; Chung, Gyung-Tae et al. (2011) Molecular characterization of methicillin-resistant Staphylococcus aureus isolates in Korea. J Clin Microbiol 49:1979-82
Allen, George P; Deshpande, Lalitagauri M (2010) Determination of the mutant selection window for clindamycin, doxycycline, linezolid, moxifloxacin and trimethoprim/sulfamethoxazole against community-associated meticillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents 35:45-9
Nadarajah, Rohan; Post, Linda R; Liu, Catherine et al. (2010) Detection of vancomycin-intermediate Staphylococcus aureus with the updated Trek-Sensititre System and the MicroScan System. Comparison with results from the conventional Etest and CLSI standardized MIC methods. Am J Clin Pathol 133:844-8
Kato, Yoshihisa; Suzuki, Takahisa; Ida, Takashi et al. (2010) Genetic changes associated with glycopeptide resistance in Staphylococcus aureus: predominance of amino acid substitutions in YvqF/VraSR. J Antimicrob Chemother 65:37-45
Feng, Jie; Lupien, Andréanne; Gingras, Hélène et al. (2009) Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance. Genome Res 19:1214-23
Périchon, Bruno; Courvalin, Patrice (2009) VanA-type vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 53:4580-7
Patel, M; Waites, K B; Hoesley, C J et al. (2008) Emergence of USA300 MRSA in a tertiary medical centre: implications for epidemiological studies. J Hosp Infect 68:208-13

Showing the most recent 10 out of 28 publications